文献
J-GLOBAL ID:202202283162222427
整理番号:22A0478491
FDA有害事象報告システムにおけるGLP-1受容体作動薬と糖尿病性ケトアシドーシスとの関連【JST・京大機械翻訳】
The association between GLP-1 receptor agonist and diabetic ketoacidosis in the FDA adverse event reporting system
著者 (7件):
Yang Zheng
(Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China)
,
Yu Meng
(Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China)
,
Mei Mei
(Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China)
,
Chen Chongxin
(Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China)
,
Lv Yuhuan
(Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China)
,
Xiang Linyu
(Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China)
,
Li Rong
(Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China)
資料名:
Nutrition, Metabolism and Cardiovascular Diseases
(Nutrition, Metabolism and Cardiovascular Diseases)
巻:
32
号:
2
ページ:
504-510
発行年:
2022年
JST資料番号:
W3195A
ISSN:
0939-4753
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)